BRAFTOVI 75 MG CAP DURA CT BL AL AL X 42
Apresentação · Câmara de Regulação do Mercado de Medicamentos (CMED), Secretaria Executiva exercida pela Agência Nacional de Vigilância Sanitária (ANVISA) · Brasil
-
Número de registro
1211004830028 -
GGREM
522723010091301 -
Código de barras
7891045164955
O que a fonte publica
- Detentor do registro
- PFIZER BRASIL LTDA
- Princípios ativos
- ENCORAFENIBE
- Embalagem
- 75 MG CAP DURA CT BL AL AL X 42
- Regime de dispensação
- Tarja Vermelha
- Tipo de produto
- Novo
- Classe terapêutica
- L1H4 - INIBIDORES PREOTEÍNA KINASE ANTINEOPLÁSICOS, BRAF/MEK
- Prescrição
- Sob prescrição ou restrito
Nomes pelos quais este registro é encontrado
Dados completos da fonte
{
"name": "BRAFTOVI 75 MG CAP DURA CT BL AL AL X 42",
"holder": "PFIZER BRASIL LTDA",
"stripe": "Tarja Vermelha",
"barcodes": [
"7891045164955"
],
"confaz87": false,
"currency": "BRL",
"marketed": null,
"ggremCode": "522723010091301",
"useDomain": "unknown",
"capApplies": null,
"icmsExempt": false,
"holderTaxId": "61.072.393/0001-33",
"priceRegime": "Regulado",
"productName": "BRAFTOVI",
"productType": "Novo",
"hospitalOnly": false,
"presentation": "75 MG CAP DURA CT BL AL AL X 42",
"sourceStatus": null,
"supplyRegime": "Tarja Vermelha",
"factoryPrices": {
"icms-0": "7631.04",
"icms-12": "8671.64",
"icms-17": "9194.02",
"icms-18": "9306.14",
"icms-19": "9421.04",
"icms-20": "9538.80",
"icms-21": "9659.55",
"icms-22": "9783.38",
"icms-23": "9910.44",
"icms-17.5": "9249.74",
"icms-19.5": "9479.55",
"icms-20.5": "9598.80",
"icms-22.5": "9846.51",
"icms-12-alc": "7742.54",
"icms-17-alc": "8208.95",
"icms-18-alc": "8309.06",
"icms-19-alc": "8411.63",
"icms-20-alc": "8516.78",
"icms-21-alc": "8624.59",
"icms-22-alc": "8735.16",
"icms-23-alc": "8848.60",
"withoutTaxes": "6813.43",
"icms-17.5-alc": "8258.70",
"icms-19.5-alc": "8463.88",
"icms-20.5-alc": "8570.34",
"icms-22.5-alc": "8791.52"
},
"pisCofinsList": "Negativa",
"substanceText": "ENCORAFENIBE",
"targetSpecies": [],
"consumerPrices": {
"icms-0": "10236.77",
"icms-12": "11632.70",
"icms-17": "12333.45",
"icms-18": "12483.86",
"icms-19": "12637.99",
"icms-20": "12795.96",
"icms-21": "12957.94",
"icms-22": "13124.06",
"icms-23": "13294.50",
"icms-17.5": "12408.20",
"icms-19.5": "12716.48",
"icms-20.5": "12876.45",
"icms-22.5": "13208.74",
"icms-12-alc": "10703.61",
"icms-17-alc": "11348.39",
"icms-18-alc": "11486.79",
"icms-19-alc": "11628.59",
"icms-20-alc": "11773.95",
"icms-21-alc": "11922.99",
"icms-22-alc": "12075.85",
"icms-23-alc": "12232.67",
"withoutTaxes": "9419.16",
"icms-17.5-alc": "11417.17",
"icms-19.5-alc": "11700.82",
"icms-20.5-alc": "11847.99",
"icms-22.5-alc": "12153.76"
},
"invalidBarcodes": [],
"activeSubstances": [
"ENCORAFENIBE"
],
"therapeuticClass": "L1H4 - INIBIDORES PREOTEÍNA KINASE ANTINEOPLÁSICOS, BRAF/MEK",
"commercialisation": {
"year": 2025,
"marketed": true
},
"priceAnalysisNote": null,
"useDomainEvidence": {
"basis": "unreviewed",
"field": null,
"value": null,
"version": 1,
"sourceId": "br.anvisa.cmed-prices"
},
"patientEligibility": "not-assessed",
"registrationNumber": "1211004830028",
"targetSpeciesStatus": "not-reported",
"administrativeStatus": "unknown",
"prescriptionCategory": "prescription-or-restricted",
"prescriptionRequired": true,
"therapeuticClassCode": "L1H4",
"commercialDestination": null,
"registrationNumberFlag": null
}
Leia este registro a partir do seu próprio software
O mesmo registro, com todos os campos e sua procedência, está a uma requisição de distância. A chave de API é gratuita e funciona imediatamente.
curl -G "https://api.medifontis.com/v1/drugs/record" \
-H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
--data-urlencode "country=br" \
--data-urlencode "sourceId=br.anvisa.cmed-prices" \
--data-urlencode "id=br:cmed:presentations:522723010091301"